Biomedical and biological mass spectrometry.

Area of Science:

• Biological and Biomedical Mass Spectrometry
• Analytical Chemistry
• Biochemistry

Background:

• Biological and biomedical mass spectrometry has undergone significant advancements between 1987 and 2001.
• The field has evolved dramatically over the past 15 years.
• Key innovations have propelled mass spectrometry's capabilities in life sciences.

Purpose of the Study:

• To review the progress in biological and biomedical mass spectrometry from 1987-2001.
• To highlight the impact of soft ionization methods on biomolecular analysis.
• To discuss the applications of mass spectrometry in research and drug discovery.

Main Methods:

• Review of publications in the MEDLINE database (1987-2001).
• Focus on soft ionization techniques like electrospray ionization (ESI) and matrix-assisted laser desorption ionization (MALDI).
• Description of mass spectrometer characteristics relevant to biological research.

Main Results:

• Soft ionization methods (ESI, MALDI) enable ionization of large, polar, and labile biomolecules (proteins, peptides, nucleic acids).
• These innovations have driven progress in mass spectrometric technology and biochemical/biotechnological research.
• Mass spectrometry is a powerful tool for structural determination, drug metabolism studies (pharmacokinetics, toxicokinetics), and drug discovery.

Conclusions:

• Innovative soft ionization techniques are crucial for modern biological and biomedical mass spectrometry.
• Mass spectrometry plays a vital role in advancing biochemistry, biotechnology, and molecular biology.
• The technology is indispensable for efficient drug discovery and development processes.